Collectively, these data indicate that p53 and β-catenin have a functional crosstalk in liver cancer cells, i.e, p53 negatively regulates nuclear accumulation of β-catenin and β-catenin-mediated transcriptional response. This evidence concerns the gene TP53 and liver cancer.